The opioid crisis is a stark reminder of the dire human cost of corporate corruption and a deeply flawed for-profit medical system in America.
P.B.M.s, hired to manage drug costs, engaged in profit-driven practices that often prioritized their financial interests over patients’ health and safety.
Investigations revealed P.B.M.s accepted payments from opioid manufacturers to allow unrestricted access to painkillers, even as overdose deaths surged across the country.
The middlemen's ties to pharmaceutical companies illustrate how everything, even patient protections, can be compromised in this pay-to-play drug pricing system.
Collection
[
|
...
]